CI

At a glance

ClinicalIndex Comparison Record
Phase 2Recruiting· 16 target
Drug / intervention
Drospirenonedrug
Likely dose
Drospirenone 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06345560
NCT06345560Phase 2RecruitingOn TrackUpdated 3mo ago

Pharmacokinetics of Drospirenone Only Pills in Obese Thai Women: A Pre- and Post-Bariatric Surgery Study

Chulalongkorn University·interventional·Posted Apr 3, 2024·Updated Mar 19, 2026

In Brief

A Phase 2 clinical trial evaluating Drospirenone for Contraception. Currently recruiting, targeting 16 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate whether bariatric surgery affects Drospirenone only pills absorption

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesThailand
Collaborators--

Timeline

Phase 2RecruitingOverdue
20252026
First PostedApr 3, 2024
Enrollment StartApr 18, 2024
Primary CompletionJul 1, 2026
TodayJul 1, 2026
Enrollment to primary: 2.2 yearsPosted 2.2 years ago

Interventions

Drospirenonedrug

4 mg tablet once daily